Loading...

Financial Statements

Anika Therapeutics Inc.

Anika Therapeutics Inc. (ANIK)

Healthcare

Balance Sheet Statement

Download ANIK income statement Download ANIK income statement
Year 2009201020112012201320142015201620172018
Cash and cash equivalents 24.4328.2035.7844.0763.33100.16110.71104.26133.2689.04
Short-term investments -----6.7527.7520.5024.0069.97
Cash and short-term investments 24.4328.2035.7844.0763.33106.91138.46124.76157.26159.01
Receivables 11.7814.8217.3121.4618.7417.1521.6527.6023.8220.77
Inventories 8.558.957.308.2811.0012.4114.9415.9822.0421.30
Property, Plant & Equipment Net 35.7536.9836.4735.1132.9431.6740.1152.3056.1854.11
Goodwill and Intangible Assets 39.9334.8632.0329.4028.4423.2319.1417.4418.8517.04
Long-term investments ----------
Tax assets 5.692.381.922.030.66-----
Total non-current assets 30.7724.3823.5418.6911.138.747.628.676.054.09
Total current assets 79.6072.6168.7164.6861.4554.9759.3169.8176.2976.05
Total assets 129.43128.94132.84142.07156.04192.81235.75240.25282.62278.99
Payables 6.359.694.302.342.791.208.302.306.753.14
Short-term debt 1.601.601.601.60------
Total current liabilities 16.5219.3714.5414.459.285.9717.288.8013.0711.29
Long-term debt 12.8011.209.608.00------
Total debt 14.4012.8011.209.60------
Deferred revenue 10.858.107.895.032.240.100.07---
Tax Liabilities --0.451.808.71-4.20---
Deposit Liabilities ----------
Total non-current liabilities 30.7724.3823.5418.6911.138.747.628.676.054.09
Total liabilities 47.2943.7538.0833.1420.4114.7124.9017.4719.1315.38
Other comprehensive income --2.55-3.07-2.65-1.70-4.50-6.65-7.32-4.78-5.53
Retained earnings (deficit) 21.4725.7934.2546.0166.58104.90135.66168.21199.51218.23
Total stockholders equity ----------
Investments -----6.7527.7520.5024.0069.97
Net Debt -10.03-15.40-24.58-34.47-63.33-106.91-138.46-124.76-157.26-159.01
Other Assets 5.084.353.753.571.521.371.392.103.211.85
Other Liabilities 8.578.088.6410.516.494.778.986.506.338.15

Anika Therapeutics Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Anika Therapeutics Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.